As of 2024-12-12, the Fair Value of AlzeCure Pharma AB (ALZCUR.ST) is -2.03 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.20 SEK, the upside of AlzeCure Pharma AB is -269.26%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -50.86 | -71.37 | -77.78 | -56.24 | -37.17 | -58.68 |
| YoY growth | -41.33% | -40.32% | -8.99% | 27.70% | 33.91% | -5.81% |
| Market Cap (mil) | 105.95 |
| P/E | |
| Forward P/E |
| EPS | -0.41 |
| Avg earnings growth rate | -5.81% |
| TTM earnings | -35.87 |